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CHAPTER VI 

CONCLUSIONS AND SUMMARY 
1. Conclusions 
In the preceeding chapters an attempt was made to valuate the epidemi­
ological situation in the Netherlands. 
The arising of contagious sources in a community of which the lower age 
groups (0 - 20 years) remain virtually uninfected with tubercle bacilli 
presents an increasing danger in the future. 
This danger is illustrated by a description of an epidemic caused by one 
source of tuberculous infection in a largely tuberculin negative community 
of young adults. 
As large scale vaccination with BeG was nol carried Ollt in the Netherlands 
the efficacy of the tuberculin test to trace tuberculin-converted contacts is 
clearly demonstrated. 
Tn this context the merits of chemoprophylaxis with INH ,re discussed and 
a review of the most important human and animal trials on chemoprophy­
laxis with INH is presented. 
It is shown that in 1960 a number of uncertainties prevailed to use INH 
prophylactically on a large scale in the case of recent tuberculin-converted 
adults. 
It was the close observation of this epidemic spread of tuberculous infection 
among adults which resulted in sufficient material, and in sufficient motives 
to start the trial which is described in the last chapter. 
Secondary prophylaxis with INH proved to offer complete protection 
against the development of active tuberculosis in young adult tuberculin 
converters. 
During a seven-year follow-up period this rate of protection remained 
unchanged. 
This trial also resulted in some observations concerning the behaviour of the 
standard Mantoux test of which the most important observation was that 
INH medication during one year did not affect tuberculin sensitivity 
expressed by this test. 
Close observation of the participants of this trial ilIicited no toxic effects or 






A review is given of the development of the tuberculosis situation in 
the Netherlands. 
The incidence and prevalence of tuberculosis has decreased to a very low 
level as a major result of tuberculosis control by tuberculosis clinics. 
periodical X-ray surveys and adequate treatment of all known cases of 
active tuberculosis. 
Since no systematic BeG vaccination was instituted in the past. the tuber­
culin test has gained importance in tuberculosis control in the Netherlands, 
as it is the only way to detect sources of tuberculous infection and those 
recently infected. 
Chapter /I 
The merits of isonicotinic acid hydrazide ( INH) as a powerful 
tuberculostatic drug are reviewed. 
The effect of prophylactic medication with lNH is illustrated by a review 
of the most important human and animal trials. rhe different results of 
these trials suggest differences in materials and methods. 
No clear evidence of the effect of secondary prophylaxis with INH in 
young adults was available in 1961l. 
Chapter /II 
An observation of a mass tuberculous infection in a predominantly 
tuberculin-negative community is described. 
The importance of systematic usc of the tuberculin test. with the aid of 
which the development of secondary infection sources was prevented. is 
shown. 
Chapter IV 
In this chapler consideration is given to the risks of active tuberculosis 
in young adults as a result of recent infection by tubercle bacilli. 
The necessity to institute prophylactic medication (in 196U) is discussed. 
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Chapler V 
A controlled trial is described in which secondary prophylaxis with INH 
was used. 
In a group of 1:13 participants who received INH (600 mg daily during 6 
months followed by 400 mg during another 6 months) the incidence of 
active tuberculosis amounted to 0.8 0/ during treatment. During a seven­
year follow-up this incidence remained unchanged. 
In a group of 128 participants who received a placebo, the incidence was 
7,/ during treatment and 9.4/ during the following years. 
Some observations concerning the possible influence of INH medication 
on tuberculin sensitivity, the evaluation of small indurations following con­
version, and the relation between the degree of tuberculin sensitivity and 
tuberculosis incidence, are reported. 
No toxic phenomena were observed among 133 participants receiving INH 
during one year. 
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